Psychiatry · Kansas City, KS
NPI
1730541426
Since 2016
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3901 Rainbow Blvd
Kansas City, KS, 66160
Phone (913) 588-1300
Groups this clinician bills Medicare through
Medicare paid, 2024
$115K
2,814 services
Medicare patients, 2024
283
Average age 61
Drug cost, 2024
$886K
2,843 prescriptions
Company payments, 2025
$0
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tyler R Kjorvestad was code G2212 (prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or), 770 times for 24 patients. In total Tyler R Kjorvestad billed 2,814 services in 19 codes, and Medicare paid $115K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 770 | 24 | $23.70 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 510 | 140 | $12.69 | $6,473 |
| 99214 Office E&M - Established | Facility | 317 | 141 | $59.89 | $19K |
| 99215 Office E&M - Established | Facility | 248 | 32 | $63.74 | $16K |
| G2083 Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, | Facility | 237 | 16 | $26.96 | $6,390 |
| 99214 Office E&M - Established | Office | 152 | 83 | $77.54 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 130 | 69 | $11.98 | $1,557 |
| 90792 Psychotherapy - Nongroup | Facility | 36 | 36 | $134.20 | $4,831 |
| 99233 Hospital E&M - Subsequent | Facility | 23 | 17 | $91.03 | $2,094 |
| 99232 Hospital E&M - Subsequent | Facility | 17 | 14 | $60.69 | $1,032 |
By year: 2022 $65K for 1,096 services; 2023 $81K for 1,845 services; 2024 $115K for 2,814 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tyler R Kjorvestad prescribed most often to Medicare patients was Spravato (Esketamine Hcl), with 588 prescriptions and refills. In total Tyler R Kjorvestad wrote 2,843 Medicare prescriptions that cost $886K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spravato Esketamine Hcl | 588 | 588 | 20 | $643K |
| Mirtazapine Generic | 156 | 399 | 55 | $3,199 |
| Clonazepam Generic | 148 | 161 | 29 | $1,246 |
| Trazodone Hcl Generic | 134 | 316 | 53 | $2,360 |
| Bupropion Xl Bupropion Hcl | 107 | 305 | 41 | $4,109 |
| Alprazolam Generic | 97 | 112 | 17 | $585 |
| Buspirone Hcl Generic | 95 | 214 | 33 | $1,906 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 92 | 234 | 20 | $4,214 |
| Lamotrigine Generic | 79 | 175 | 23 | $1,463 |
| Duloxetine Hcl Generic | 77 | 211 | 33 | $1,974 |
| Escitalopram Oxalate Generic | 71 | 203 | 24 | $1,557 |
| Quetiapine Fumarate Generic | 69 | 123 | 22 | $1,095 |
| Fluoxetine Hcl Generic | 64 | 168 | 23 | $745 |
| Hydroxyzine Hcl Generic | 54 | 76 | 23 | $1,589 |
| Aripiprazole Generic | 51 | 119 | 15 | $1,528 |
Brand drugs: - claims; generic drugs: 2,130 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tyler R Kjorvestad $0 (- in general payments such as food, travel and fees) from 2 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.